Pillstats
Rx only · Tablet · Oral

Perphenazine

Perphenazine

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US24 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers7 labelers
Packages45
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.080$0.160$0.241$0.321Dec 2025Apr 2026Jul 2026
$0.249
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
7
Active US suppliers
53%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.0K8.1K12K16K2025 Q12025 Q22025 Q32025 Q42026 Q1
11K
Rx · 2026 Q1
736K
Units dispensed
+3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Pharmaceuticals USA Inc.unknown12SUPPLYING
Zydus Lifesciences Limitedunknown12SUPPLYING
Macleods Pharmaceuticals Limitedunknown8SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown4SUPPLYING
Golden State Medical Supply, Inc.unknown4SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING
Chartwell RX, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.